معرفی
Katherine Harvey, MD, MPH, is an Assistant Professor of Medicine at Yale School of Medicine, specializing in Medical Oncology and Hematology. She joined Yale Cancer Center in 2015 after completing her fellowship at Yale and currently practices at Smilow Cancer Hospital Care Center in Torrington, Connecticut. Her clinical focus includes gastrointestinal cancers and blood disorders such as anemia, leukopenia, and pediatric-type follicular lymphoma (PTFL). She actively participates in multiple clinical trials for advanced cancers, including lymphoma, lung, pancreatic, and prostate cancers.
Dr. Harvey holds an MD from the University of Connecticut School of Medicine (2008) and an MPH from the Harvard School of Public Health (2012). Her research interests align with her clinical work, emphasizing translational studies in oncology and hematology. She collaborates closely with multidisciplinary teams at Yale and local institutions to advance patient care through innovative treatments.
Her current roles include Sub Investigator in several high-profile trials, such as a Phase 2 study for CD30-positive T-cell lymphoma and a Phase III trial for metastatic EGFR-mutant non-small cell lung cancer. While no specific awards are listed, her contributions to clinical research are evident through her trial leadership and academic publications (not explicitly detailed here).
Dr. Harvey’s clinical and academic affiliations include Yale Cancer Center, the Department of Internal Medicine, and the Smilow Cancer Hospital network. She is dedicated to advancing personalized oncology care and improving outcomes for patients with complex hematologic and oncologic conditions.